Navigation Links
Gentag, Inc. Engages US and UK Firms to Explore Strategic Options
Date:3/17/2009

LONDON and WASHINGTON, March 17 /PRNewswire/ -- Gentag, Inc. (Gentag) announced today that its Board of Directors has engaged VCG & Associates Inc. and Talisman Management Ltd. to assist the Company relating to the sale or license of all or parts of its IP portfolio. VCG & Associates Inc. will provide assistance relating to pharmaceutical and medical diagnostic uses on a global or specific geographic basis. Talisman Management Ltd. will evaluate all other opportunities. Gentag does not anticipate making another announcement in this regard to this matter unless its Board has approved a definitive transaction.

"Gentag has pioneered the concept of combining cell phones with MEMS, RFID and other sensors to create low cost ubiquitous cell phone-sensor networks. Cell phone-sensor networks will broadly impact healthcare, medical diagnostics, Homeland Security and other emerging markets such as 'smart' homes. Currently, the company and its partners are developing innovative low cost monitoring solutions for diabetes, prostate cancer, blood pressure and other common health conditions such as obesity that can be monitored directly by cellular telephones," stated Dr. John P. Peeters, President of Gentag. "With the global adoption of RFID cell phones by all major OEMs and the need to reduce medical costs worldwide our patented solution is creating immediate new market opportunities for the healthcare, IT, telecommunication and defense industries. We look forward to working with VCG & Associates Inc. and Talisman Management Ltd. to assist us in exploring our options and to maximize the full potential of our technology portfolio."

About Gentag, Inc. - Gentag, Inc. is a technology development company focusing on innovative, low-cost, wireless sensor network technologies based on cell phones. The company owns unique intellectual property relating to cell phone-sensor combinations and wireless sensor networks, including US patents 6,031,454, 7,109,859, 7,148,803, 7,461,972, 7,492,254 and other pending or approved US and international patents. The effective combination of cell phones with a disposable wireless sensor platform has led to a variety of diagnostic applications providing consumers, physicians, and various industries with instant access to vital information over established wireless networks, the Internet, and client-specific databases. The company is the recipient of the 2008 North American Technology Innovation Award from Frost & Sullivan.

About VCG & Associates Inc. - VCG & Associates, Inc. is an independent US strategic marketing and contract national account organization specializing in the commercialization, licensing and acquisition/disposition of pharmaceutical, biotech, and medical device products.

About Talisman Management, Ltd. - Talisman Management Ltd. is an advisory group based in London and its geographic focus is primarily on Europe and North America.


'/>"/>
SOURCE Gentag, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. MMR Information Systems, Inc. Engages Houlihan Smith
2. Shire Engages Palio
3. Three Firms, Two Training Programs Garner Greater Baltimore Committees 2009 Bioscience Awards
4. Amylin Pharmaceuticals Confirms Receipt of Director Nomination Notices
5. Genomma Lab Reaffirms Zero Ownership Stake in the Laser Hair Removal Chains Neoskin and Depilite
6. Mylan Confirms First-to-File Patent Challenge Relating to Lescol(R)
7. Sigma-Aldrich (Nasdaq: SIAL) Reports 18.5% Gain in Q3 2008 Diluted EPS and Reaffirms Full Year 2008 Diluted EPS Forecast. Q3 2008 Sales Increase 7.4%. Buyback Authorization Increased by 10 Million Shares.
8. Neogen Honored by Forbes; Two Brokerage Firms Initiate Coverage
9. China Sky One Medical, Inc. Starts Production at Newly Acquired Facility and Reaffirms Guidance
10. Senetek Affirms Strong Financial Position
11. Online Systems Engineering Master's Program Attracts Engineers from Fortune 500 Firms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , ... of Cancer Research, London (ICR) and ... with SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple ... as MUK nine . The University of ... is partly funded by Myeloma UK, and ICR will perform ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... optimization firm for the life sciences and healthcare industries, announces a presentation by ... Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
Breaking Biology Technology:
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... 13, 2017 According to a new market research ... Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and ... is expected to grow from USD 14.30 Billion in 2017 to USD ... 17.3%. ... MarketsandMarkets Logo ...
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
Breaking Biology News(10 mins):